BiotechTube
Home/NeRRe Therapeutics/Dr. Mary Kerr
DM

Dr. Mary Kerr

Chief Executive Officer

NeRRe Therapeutics

Therapeutic Areas

RespiratoryDermatologyNeurology

NeRRe Therapeutics Pipeline

DrugIndicationPhase
OrvepitantChronic Refractory CoughPhase 2